International Biotechnology Trust PLC Fibrogen Inc Transaction History

International Biotechnology Trust PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$9.93 - $15.39 $195,621 - $303,183	-19,700 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $444,249 - $703,872	-11,700 Reduced 37.26%	19,700 $716,000
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $22.4 Million - $26.7 Million	-397,233 Reduced 92.67%	31,400 $1.46 Million
Q3 2018 Nov 13, 2018	BUY	$56.3 - $67.25 $22.4 Million - $26.7 Million	397,233 Added 1265.07%	428,633 $5.97 Million
Q3 2017 Mar 02, 2018	BUY	$33.4 - $53.9 $1.05 Million - $1.69 Million	31,400	31,400 $1.69 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.